Clinic for Ruminants, Faculty of Veterinary Science, University of Munich, Sonnenstr. 16, 85764 Oberschleissheim, Germany.
Prev Vet Med. 2012 Jun 1;105(1-2):49-58. doi: 10.1016/j.prevetmed.2012.02.008. Epub 2012 Mar 3.
A case control study on farm level was conducted at the Clinic for Ruminants, LMU Munich, to identify possible risk factors associated with the observed increase in numbers of calves showing clinical signs of Bovine Neonatal Pancytopenia (BNP) since 2006 in southern Germany. Interviews were conducted between August 2008 and June 2010. The characteristics of 56 dairy farms with at least one confirmed case of BNP (thrombocytopenia and leukocytopenia and/or typical findings in post-mortem examination and bone marrow histology) were compared with those of two sets of 50 control dairy farms each, with no history of BNP. The first set of 50 control farms was selected randomly from veterinary practices which had never observed a BNP case on the farms they serviced. The second set of 50 control farms was matched by the veterinary practices which had provided case farms. Two separate analyses were conducted: (1) case farms (n=56) vs. randomly selected control farms (n=50) and (2) case farms (n=56) vs. a matched set of control farms (n=50). All variables with p<0.2 in the univariable analysis were included in stepwise logistic regression models. In the first analysis, only the use of PregSure(®) BVD vaccine was positively associated with BNP with an odds ratio of 1292 (95% CI: 114-14707). In the second analysis, conditional logistic regression models did not converge, therefore non-conditional logistic regression models were conducted. In the non-conditional analysis five variables remained in the model, three of which were negatively associated with BNP: the use of vitamin E and selenium, the frequent use of mastitis tubes, and the use of stem growth regulators in grain production. The use of prophylactic measures (such as control of parasites or vaccination of calves against respiratory disease) was positively associated with BNP with an odds ratio of 14.3 as well as the use of PregSure(®) BVD vaccine with an odds ratio of 426 (95% CI: 20-9095).
在慕尼黑大学临床反刍动物科进行了一项基于农场层面的病例对照研究,以确定自 2006 年以来德国南部观察到患有牛新生粒细胞减少症(BNP)临床症状的牛数量增加的相关潜在风险因素。访谈于 2008 年 8 月至 2010 年 6 月进行。将 56 个奶牛场的特征与至少有一个确诊 BNP 病例(血小板减少症和白细胞减少症和/或死后检查和骨髓组织学的典型发现)的两组 50 个对照奶牛场的特征进行了比较,每组有 50 个对照奶牛场,没有 BNP 病史。第一组 50 个对照奶牛场是从兽医诊所中随机选择的,这些兽医诊所从未在其服务的农场中观察到 BNP 病例。第二组 50 个对照奶牛场由提供病例奶牛场的兽医诊所匹配。进行了两次独立分析:(1)病例奶牛场(n=56)与随机选择的对照奶牛场(n=50)和(2)病例奶牛场(n=56)与匹配的对照奶牛场(n=50)。单变量分析中 p<0.2 的所有变量均包含在逐步逻辑回归模型中。在第一次分析中,只有使用 PregSure(®) BVD 疫苗与 BNP 呈正相关,优势比为 1292(95%CI:114-14707)。在第二次分析中,条件逻辑回归模型无法收敛,因此进行了非条件逻辑回归模型。在非条件分析中,有五个变量保留在模型中,其中三个与 BNP 呈负相关:维生素 E 和硒的使用、经常使用乳腺炎管以及谷物生产中使用茎生长调节剂。使用预防性措施(如寄生虫控制或牛呼吸道疾病疫苗接种)与 BNP 呈正相关,优势比为 14.3,使用 PregSure(®) BVD 疫苗与 BNP 呈正相关,优势比为 426(95%CI:20-9095)。